---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-067858"
form_type: "8-K"
ticker: "LFST"
cik: "0001845257"
company_name: "LifeStance Health Group, Inc."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:27:48.182579+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# LifeStance Q4 revenue $382M (+17% YoY); net income $11.7M; $100M buyback; Chairman transition

## Summary
- Q4 revenue $382.2M (+17% YoY); full-year revenue $1.42B (+14% YoY).
- Q4 net income $11.7M vs loss $7.1M; full-year net income $9.7M vs loss $57.4M.
- Adjusted EBITDA Q4 $48.8M (+49% YoY); full-year $157.7M (+32% YoY).
- 2026 guidance: revenue $1.615B-$1.655B; Adjusted EBITDA $185M-$205M.
- Board approved $100M share repurchase; Kenneth Burdick transitions to non-executive Chairman effective Mar 16, 2026.

## SEC filing metadata
- accession: 0001193125-26-067858
- form_type: 8-K
- ticker: LFST
- cik: 0001845257
- company_name: LifeStance Health Group, Inc.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/0001193125-26-067858-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845257/000119312526067858/lfst-20260225.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-067858
- JSON: https://secwatch.observer/filing/0001193125-26-067858.json
- Plain text: https://secwatch.observer/filing/0001193125-26-067858.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.